Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

Front Oncol. 2023 Apr 14:13:1187014. doi: 10.3389/fonc.2023.1187014. eCollection 2023.

¹ Laboratory of Experimental Oncology, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Castellana Grotte, Italy.
² Data Science Unit, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Castellana Grotte, Italy.
³ Scientific Direction, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Castellana Grotte, Italy.
⁴ Medical Oncology Unit, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Castellana Grotte, Italy.
⁵ Complex Operating Unit Oncologia, Local Health Authority Napoli 2 Nord, P.O. "S.M. delle Grazie", Naples, Italy.
⁶ Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania "Luigi Vanvitelli", Naples, Italy.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.862116.].

Keywords: angiogenesis; biomarkers; cancer progression; gastric cancer; target therapy.